When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KDMN - Kadmon announces topline results from successful study of KD025 in GVHD
Kadmon Holdings Inc.
Kadmon Holdings (NYSE:KDMN) announces topline results from the primary analysis of a pivotal Phase 2 clinical trial, ROCKstar, evaluating lead drug belumosudil (KD025) in patients with chronic graft-versus-host disease (cGVHD) who have received at least two prior lines of systemic therapy. The company reported preliminary positive results in November 2019.
More news on: Kadmon Holdings, Inc., Healthcare stocks news, Stocks on the move,